$SRPT

$18.89 +$0.91 (5.06%) Close

$SRPT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 105.6M shares outstanding

Who owns SRPT?

By type of holder

Institutions 100.0% Insiders 0.0% Everyone else 0.0%

Concentration Top 10 holders own 59.4%

BlackRock, Inc. 18.0% · State Street Corp 8.4%

Institutional ownership

100.0%

+2.5 pts vs last qtr

Institutional holders

323

-22 vs last qtr

Net shares bought

+4.3M

by institutions in Q2 2026

New / sold out

49 / 71

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +4.2M
State Street Corp +2.3M

Biggest sellers in Q2 2026

Ra Capital Management, L.P. SOLD OUT −3.9M
Aqr Capital Management LLC −2.1M

Who is planning to sell?

Notices of proposed sale, last 12 months

$417K

2 notices from 2 people

Shares covered

20.4K

0.02% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Ian M Estepan Officer $294K
Stephen Mayo Director $123K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2025

+70.2%

+6.88% a year

Each share's claim on the business

−41.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$25M vs $1.1B

over 9 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years69% 3–5 years2% 1–3 years19% Under 1 year10%

Quarterly turnover

18.9%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting SRPT on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	19.0M	17.98%	+4.2M (+28.7%)	≤2021	0.0%
Shares held by quarter Peak holding19.0M (Q2'26) Change over 8 quarters+8.0M Share of the company17.980% BlackRock, Inc.'s full portfolio →
SS State Street Corp	8.9M	8.44%	+2.3M (+34.8%)	≤2021	0.0%
Shares held by quarter Peak holding8.9M (Q2'26) Change over 8 quarters+4.6M Share of the company8.440% State Street Corp's full portfolio →

BlackRock, Inc.

19.0M

% of company

17.98%

Change vs last qtr

+4.2M (+28.7%)

Held since

≤2021

State Street Corp

8.9M

% of company

8.44%

Change vs last qtr

+2.3M (+34.8%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Sarepta Therapeutics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting SRPT on Form N-PORT; together they hold 49.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Small-Cap ETF iShares Trust	$114M	6.4M	6.02%	0.10%	June 30, 2026
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$80.2M	4.5M	4.22%	0.75%	June 30, 2026

iShares Core S&P Small-Cap ETF

iShares Trust

Position value

$114M

% of company

6.02%

% of the fund

0.10%

As of

June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$80.2M

% of company

4.22%

% of the fund

0.75%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Sarepta Therapeutics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BR Barry Richard Insider	3.2M	3.06%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.060% Barry Richard's insider activity →
ID Ingram Douglas S Insider	929.4K	0.88%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.880% Ingram Douglas S's insider activity →

Barry Richard

Insider

3.2M

% of company

3.06%

Change vs last qtr

—

Held since

—

Ingram Douglas S

Insider

929.4K

% of company

0.88%

Change vs last qtr

—

Held since

—

14 more holders behind a free account

See every insider and 5%+ holder of Sarepta Therapeutics, Inc..

Comments